Valiant Navion™ VNMC4040C55TU (UDI 00763000101084)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMC4040C55TU VAL NAV CS · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00763000101084), received between Dec 31, 2018 and Oct 12, 2023 — classified as 3 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Leak/Splash” (2 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Feb 12, 2021Class IOpen, Classified
Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.
Z-1201-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Leak/Splash2
- Adverse Event Without Identified Device or Use Problem1
- Defective Component1
- Detachment of Device or Device Component1
- Device Damaged by Another Device1
- Difficult to Remove1
- Fracture1
- Material Deformation1
Patient problems
- Injury2
- No Clinical Signs, Symptoms or Conditions2
- Intimal Dissection1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 12, 2023Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT ((B)(6)) WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACOABDOMINAL AORTIC ANEURYSM. 5 E NDURANT STENT GRAFTS WERE ALSO IMPLANTED TO EXCLUDE THE ABDOMINAL ANEURYSM. IT WAS REPORTED APPROXIMATELY 2 YEARS POST THE INDEX PROCEDURE, A FOLLOW UP CT REVEALED STABLE THORACIC AORTIC ECTASIA/ANEURYSM REMAINED STABLE, BUT SMALL ENDOLEAKS WERE OBSERVED ALONG THE THORACOABDOMINAL ENDOLUMINAL STENT GRAFT WITHIN THE DESCENDING THORACIC AORTA. THE TYPE OF ENDOLEAK WAS NOT SPECIFIED. PER THE PHYSICIAN THE CAUSE OF THE UNKNOWN ENDOLEAK IS UNDETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17918764 ↗MalfunctionJul 7, 2023Fracture; Leak/Splash; Detachment of Device or Device Component; Fracture; Leak/Splash; Detachment of Device or Device Component
A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A 55MM THORACIC AORTIC ANEURYSM. IT WAS REPORTED ONE MONTH POST THE INDEX PROCEDURE, FOLLOW UP CT IDENTIFIED A TYPE II ENDOLEAK. CORE LAB REVIEW OF CT IMAGING FROM (B)(6) 2023 IDENTIED A NEW STENT FRACTURE ON RING 1 OF THE NAVION GRAFT. NEW STENT RING ENLARGEMENT OF +1.8MMM WAS OBSERVED ON RING 1 OF THE STENT GRAFT. NO ENDOLEAK OR STENT RING MIGRATION WAS OBSERVED. THE MAX AORTIC DIAMETER WAS NOTED AS 72.2MM WITH THE IMAGING NOTED AS N/A FOR AORTIC ENLARGEMENT. THE CAUSE OF THE STENT FRACTURE AND STENT RING ENLARGEMENT ARE UNDETERMINED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE P ATIENT WILL BE MONITORED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17279299 ↗InjuryAug 19, 2020Difficult to Remove; Device Damaged by Another Device; Difficult to Remove; Device Damaged by Another Device
AN ENDURANT IIS, ENDURANT LIMB AND VALIANT NAVION STENT GRAFT WERE IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A 80MM SYMPTOMATIC ABDOMINAL AORTIC ANEURYSM. IT WAS DECIDED PRE-EVAR THAT THE PATIENT WAS NOT A CANDIDATE FOR OPEN REPAIR THUS THE PHYSICIAN OPTED FOR OFF-LABEL TREATMENT OF THE LARGE SYMPTOMATIC ANEURYSM. IT WAS REPORTED THAT DURING THE INDEX PROCEDURE, THAT DUE TO THE PATIENTS VERY DIFFICULT ANATOMY AND THE C-ARM IMAGING, THE DELIVERY SYSTEM OF THE VALIANT NAVION STENT GRAFT GOT CAUGHT ON THE METAL STENTS ON TOP OF THE LIMB GRAFT. MANY ATTEMPTS WERE MADE TO DISLODGE THE DELIVERY SYSTEM BUT THIS PROVED UNSUCCESSFUL. OPEN CONVERSION WAS INITIATED AND ALL THE STENT GRAFTS WERE EXPLANTED, AND THE DELIVERY SYSTEM REMOVED. THE PATIENT WAS RECOVERING IN ICU CRITICAL CARE. AS PER THE PHYSICIAN THE CAUSE OF THE EVENT WAS ANATOMY. IT WAS REPORTED THE INFRA-RENAL NECK ANGLE WAS GREATER THAN 90 DEGREES. WHEN THE ENDURANT WAS IMPLANTED, THE BEND AT THE AORTIC NECK WAS SO DRAMATIC THAT IT BENT THE GRAFT AT THE LEVEL OF FLOW DIVIDER, THUS EXPOSING THE SCALLOPED METAL STENTS ON THE LIMB. AS A RESULT, THE SPINDLE OF THE NAVION DELIVERY SYSTEM GOT STUCK ON THESE STENTS. NO ADDITIONAL CLIN
Patient problems: Injury
MAUDE report 10425313 ↗MalfunctionFeb 27, 2020Defective Component; Defective Component
A VALIANT NAVION STENT GRAFT WAS IMPLANTED IN A CADAVER AS PART OF AN R <(>&<)>D PRE-CLINICAL TRIAL AT A MEDTRONIC PHYSIOLOGICAL RESEARCH LAB. IT WAS REPORTED THAT DURING THE PROCEDURE WHEN THE DEVICE WAS REMOVED FROM ITS PACKAGING AND PREPARED FOR USE IT WAS NOTED THAT THE TAPERED TIP WAS SEPARATED FROM THE GRAFT COVER RADIOPAQUE MARKER (I.E THERE WAS A GAP NOTED). THE SPACE BETWEEN THE TAPERED TIP AND THE DISTAL EXTENT OF THE GRAFT COVER WAS APPROXIMATELY 5-7MM. IT WAS DECIDED TO CONTINUE TO IMPLANT THE DEVICE AND THE DEVICE WAS SUCCESSFULLY INTRODUCED, TRACKED AND DEPLOYED AS EXPECTED, WITH THE PROCEDURE OBSERVED BY AN ATTENDING PHYSICIAN. THE CAUSE OF THE EVENT IS UNKNOWN.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9762593 ↗InjuryMar 20, 2019Material Deformation; Material Deformation
A 6 CM VALIANT NAVION CUFF WAS IMPLANTED FOR THE ENDOVASCULAR TREATMENT OF A THORACIC PSEUDOANEURYSM AT THE ANASTOMOSIS SITE OF A PREVIOUS OPEN REPAIR. THE NAVION CUFF WAS DEPLOYED UNDER RAPID PACING. IT WAS REPORTED 3 WEEKS POST THE INDEX PROCEDURE THE PATIENT RETURNED FOR A FOLLOW UP,CTA IDENTIFIED THAT THE PSEUDOANEURYSM HAD NOT BEEN EXCLUDED. TO TREAT THIS EVENT, THE PHYSICIAN DEPLOYED A SECOND NAVION CUFF SUCCESSFULLY. PER THE PHYSICIAN, THE CAUSE OF THE EVENT IS THAT THE DEVICE HAD ¿STACKED¿ ALONG THE GREATER CURVATURE AND LOST SEAL ALTHOUGH THAT HAD NOT BEEN IDENTIFIED IN ANY WAY. IT WAS NOTED THAT THE FIRST THREE PROXIMAL STENTS MAY HAVE NESTED, RESULTING IN DISPLACEMENT OF THE PROXIMAL FABRIC EDGE ALONG THE OUTER CURVE OF THE ANATOMY. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Injury
MAUDE report 8435522 ↗InjuryDec 31, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A VALIANT NAVION STENT GRAFT WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ULCER. IT WAS REPORTED THAT THE PATIENT HAD A GOOD 1 WEEK POST OPERATIVE SCAN, HOWEVER PRESENTED WITH AN ASCENDING AORTIC DISSECTION AT THE 1 MONTH SCAN. THE DISSECTION WAS VISIBLE PROXIMAL TO AND BEHIND THE IMPLANTED DEVICE. THE PATIENT HAS NOT RECEIVED TREATMENT, AS THE PHYSICIAN OPTED FOR OBSERVATION. AS PER THE PHYSICIAN, THE CAUSE OF THE EVENT MAY BE DEVICE OVERSIZING, BUT FEELS THE ISSUE RELATES TO THE IMH AND WEAK TISSUE IN THE PATIENT'S ANATOMY. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT WILL BE MONITORED.
Patient problems: Intimal Dissection
MAUDE report 8206317 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page